Icon (ICLR) EBITDA (2009 - 2026)
Icon's (ICLR) quarterly EBITDA came in at $327.2 million in Q2 2026, down 21.67% year-over-year from $417.8 million in Q2 2025, and up 88.36% quarter-over-quarter from $173.7 million in Q1 2026.
Analysis
Icon (ICLR) EBITDA (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported EBITDA for 18 consecutive years, with $327.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA fell 21.67% year-over-year to $327.2 million in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 32.99% decrease from a year earlier, with the FY2025 full-year figure at $1.2 billion, down 32.72% from the prior year.
- EBITDA was $327.2 million for Q2 2026 at Icon, up from $173.7 million in the prior quarter.
- Over five years, EBITDA peaked at $450.4 million in Q2 2024 and troughed at $173.7 million in Q1 2026.
- A 5-year average of $376.2 million and a median of $400.9 million in 2022 frame the typical range for EBITDA.
- Across the five-year window, EBITDA jumped 124.54% in 2022 and slumped 55.53% in 2026, its largest moves.
- Over 5 years, EBITDA stood at $405.0 million in 2022, then increased by 5.22% to $426.2 million in 2023, then declined by 0.84% to $422.6 million in 2024, then sank by 50.81% to $207.8 million in 2025, then surged by 57.45% to $327.2 million in 2026.
- The last three EBITDA figures came in at $327.2 million (Q2 2026), $173.7 million (Q1 2026), and $207.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 506.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 153.38 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 327.25 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 119.89 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 14.80 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -58.55 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -409,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -6.00 Bn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -2.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 327.25 Mn |
| Mar 31, 2026 | 173.73 Mn |
| Dec 31, 2025 | 207.85 Mn |
| Sep 30, 2025 | 396.73 Mn |
| Jun 30, 2025 | 417.77 Mn |
| Mar 31, 2025 | 390.66 Mn |
| Dec 31, 2024 | 422.56 Mn |
| Sep 30, 2024 | 418.79 Mn |
| Jun 30, 2024 | 450.41 Mn |
| Mar 31, 2024 | 444.04 Mn |
| Dec 31, 2023 | 426.15 Mn |
| Sep 30, 2023 | 421.14 Mn |
| Jun 30, 2023 | 405.33 Mn |
| Mar 31, 2023 | 389.98 Mn |
| Dec 31, 2022 | 405.02 Mn |
| Sep 30, 2022 | 379.60 Mn |
| Jun 30, 2022 | 354.25 Mn |
| Mar 31, 2022 | 340.61 Mn |
| Dec 31, 2021 | 332.54 Mn |
| Sep 30, 2021 | 324.87 Mn |